In8Bio (INAB) Net Shares Issued and Repurchased (2021 - 2026)
In8Bio's (INAB) quarterly Net Shares Issued and Repurchased came in at $490500.0 in Q1 2026, down 82.74% year-over-year from $2.8 million in Q1 2025, and up 356.99% quarter-over-quarter from $107333.0 in Q4 2025.
Analysis
In8Bio (INAB) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends
In8Bio has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $490500.0 for Q1 2026.
- In Q1 2026, Net Shares Issued and Repurchased fell 82.74% year-over-year to $490500.0; the TTM figure through Mar 2026 stood at $490500.0 (down 82.74% YoY), while the FY2025 annual figure was $107333.0, down 98.32% from the prior year.
- Net Shares Issued and Repurchased came in at $490500.0 for Q1 2026 at In8Bio, up from $107333.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $6.4 million in Q4 2024 to a low of $107333.0 in Q4 2025.
- Average Net Shares Issued and Repurchased over 5 years is $1.9 million, with a median of $1.7 million recorded in 2024.
- Year-over-year, Net Shares Issued and Repurchased soared 900.16% in 2024 and slumped 98.32% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $1.8 million in 2022, then surged by 62.38% to $3.0 million in 2023, then surged by 113.15% to $6.4 million in 2024, then tumbled by 98.32% to $107333.0 in 2025, then jumped by 356.99% to $490500.0 in 2026.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $490500.0 in Q1 2026, $107333.0 in Q4 2025, and $2.8 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | In8Bio | 21.41 Mn | 21.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 490,500.00 |
| Dec 31, 2025 | 107,333.00 |
| Mar 31, 2025 | 2.84 Mn |
| Dec 31, 2024 | 6.39 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Mar 31, 2023 | 169,040.00 |
| Dec 31, 2022 | 1.85 Mn |
| Mar 31, 2022 | 801,600.00 |
| Dec 31, 2021 | 1.23 Mn |